European Union (EU) governments are stepping up pressure on Pfizer and other makers of Covid-19 vaccines to review purchase contracts, warning that millions of doses of vaccines that are no longer needed could go to waste.
This is stated in a document seen by Reuters.
This was discussed in Luxembourg by the health ministers of EU member states, although the European Commission expressed reservations about what could be achieved.
As an unnamed Polish diplomat said, the country is leading efforts to revise contracts with pharmaceutical companies, as it has more than 30 million doses in stock, and the current contract obliges it to purchase another 70 million vaccines.
Poland is calling for a review of the contract to avoid wasting money.
During the most acute phase of the pandemic, and due to fears of possible shortages, the European Commission and EU governments agreed to buy huge quantities of vaccines, mainly from the company Pfizer and the German partner Bayontek.
However, with the easing of the pandemic in Europe and the significant slowing down of vaccinations, many countries would now like to change contracts to reduce stocks and consequently costs for vaccine procurement.
Bonus video:
